In the field of transfusion and transplantation medicine, the accuracy and reliability of genotyping technology are directly related to the patients life safety and treatment effectiveness.
2026-01-14
In todays increasingly advanced precision medicine, platelet genotyping technology has become a key support for rescuing patients with difficult and severe hematological diseases.
2026-01-07
Wehe Biotech, headquartered in "China Pharmaceutical City" in Taizhou, Jiangsu since 2014, is a pioneer in the fields of transplantation diagnostics and transfusion molecular diagnostics.
2026-01-01
Weihuo Biotechnology sincerely invites you to attend the New Technologies Conference on Laboratory Testing for Organ Transplantation
2025-12-02
In clinical blood transfusions, we often hear about "ABO blood type compatibility," but for many patients requiring long-term transfusions, this is far from sufficient.
2025-10-29
In August 2025, a rare case study jointly conducted by Baoding Central Blood Station and several hospitals was published, reporting a 7-year-old boy with McLeod syndrome caused by XK gene deletion
2025-09-24
Wang Hao, CEO of Jiangsu Weihe Biotechnology Co., Ltd., as the secretary of the Party branch, organized all employees to watch the military parade ceremony in the companys lecture hall.
2025-09-03
On August 25, 2025, in Suzhou, Jiangsu, Weihe Biotech, a pioneer in Chinas transplantation, blood transfusion, and immunogenetic molecular diagnosis fields, collaborated with MGI, a creator of core to
2025-08-28
Weihe Biotech sincerely invites you to attend the Oriental Blood Transfusion Conference
2025-08-05
Recently, the overseas team of Weihe Biotech has been busy, traveling to Kuala Lumpur, Malaysia, to conduct in-depth visits to key customers in the fields of transplantation and blood transfusion
2025-07-21
Now Location：Home--News Center--Company News
